Carnitine-related alterations in patients with intermittent claudication
Medical history: cardiovascular disease, blood pressure, diabetes, gallbladder disease, pancreatitis, kidney or liver problems, thyroid-cancer history, seizures, glaucoma and other relevant conditions
Because of it's long duration of action (days to weeks), echothiophate provides round the clock control of intraocular pressure
On April 23, 2026 it came off the FDAs Category 2 do not compound list, and its one of seven peptides the FDAs Pharmacy Compounding Advisory Committee (PCAC) reviews on July 23-24, 2026 for 503A compounding eligibility
There was a period when I was literally custom-blending tinctures of 5 to 7 different botanicals to do all kinds of fancy stuff